CRISPR Therapeutics (CRSP) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-2.4
-1.75
-1.09
-0.44

Details

Expected EPS
-1.264605
Actual EPS
-1.17
Surprise EPS
0.09
Surprise Percent
+7.48%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -1.17 per share for Q4 2025.

0 Comments

Share your thoughts